Lung cancer begins in the lungs and has become the leading cause of cancer deaths in the United States for both men and women--claiming more lives than colon, ovarian, prostate, and breast cancer combined. There are two types of lung cancer: small and non-small based on the appearance of the cancer cells on the microscope. Risk for being diagnosed with lung cancer includes smoking, second hand smoke, exposure to radon gas, asbestos, and other chemicals, excessive alcohol use, and a family history. Treatments depend on the stage as well as type of lung cancer but include: surgery, chemotherapy, radiation, targeted drug therapy, and clinical trials. In stage III lung cancer, the cancer is found in the lungs as well as in the lymph nodes in the middle of the chest. Stage III lung cancer has two subtypes: IIIA and IIB. IIIA occurs if the cancer has spread to lymph nodes on the same side of the chest. IIIB occurs when the cancer has spread to the opposite side of the chest's lymph nodes.
Stage Iii Lung Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage Iii Lung Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 694 products for the study of Stage Iii Lung Cancer that can be applied to Western Blot, Flow Cytometry, Chromatin Immunoprecipitation, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.